Introduction by the Guest Editor: Oncologic Precision Medicine and the Use of Basket and Umbrella Clinical Trials.
作者信息
Doroshow James H
机构信息
From the National Cancer Institute, Bethesda, MD.
出版信息
Cancer J. 2019 Jul/Aug;25(4):243-244. doi: 10.1097/PPO.0000000000000394.
Abstract
摘要
相似文献
1
Introduction by the Guest Editor: Oncologic Precision Medicine and the Use of Basket and Umbrella Clinical Trials.客座编辑引言：肿瘤精准医学与篮子试验和伞式临床试验的应用
Cancer J. 2019 Jul/Aug;25(4):243-244. doi: 10.1097/PPO.0000000000000394.
2
New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.精准医学时代的新型临床试验设计：定义、优势、劣势及在肿瘤学中的应用概述。
Cancer Treat Rev. 2019 Feb;73:20-30. doi: 10.1016/j.ctrv.2018.12.003. Epub 2018 Dec 11.
3
National Cancer Institute Basket/Umbrella Clinical Trials: MATCH, LungMAP, and Beyond.国家癌症研究所篮子/伞式临床试验：MATCH、LungMAP 及其他。
Cancer J. 2019 Jul/Aug;25(4):272-281. doi: 10.1097/PPO.0000000000000389.
4
An overview of precision oncology basket and umbrella trials for clinicians.精准肿瘤篮子和伞式试验概述——临床医生视角
CA Cancer J Clin. 2020 Mar;70(2):125-137. doi: 10.3322/caac.21600. Epub 2020 Feb 7.
5
Biostatistical and Logistical Considerations in the Development of Basket and Umbrella Clinical Trials.篮子试验和伞式试验设计中的统计学和后勤学考虑。
Cancer J. 2019 Jul/Aug;25(4):254-263. doi: 10.1097/PPO.0000000000000384.
6
Basket Trials and the MD Anderson Precision Medicine Clinical Trials Platform.篮子试验与 MD 安德森精准医学临床试验平台。
Cancer J. 2019 Jul/Aug;25(4):282-286. doi: 10.1097/PPO.0000000000000393.
7
Future Approaches to Precision Oncology-Based Clinical Trials.基于精准肿瘤学的临床试验的未来方法。
Cancer J. 2019 Jul/Aug;25(4):300-304. doi: 10.1097/PPO.0000000000000383.
8
Definitions and statistical properties of master protocols for personalized medicine in oncology.肿瘤个性化医疗主方案的定义及统计学特性
J Biopharm Stat. 2018;28(2):217-228. doi: 10.1080/10543406.2017.1372778. Epub 2017 Oct 9.
9
From the Broad Phase II Trial to Precision Oncology: A Perspective on the Origins of Basket and Umbrella Clinical Trial Designs in Cancer Drug Development.从广谱二期临床试验到精准肿瘤学：癌症药物研发中篮子和伞式临床试验设计起源的观点。
Cancer J. 2019 Jul/Aug;25(4):245-253. doi: 10.1097/PPO.0000000000000386.
10
Geriatric Assessment: Precision Medicine for Older Adults With Cancer.老年评估：针对老年癌症患者的精准医学
J Oncol Pract. 2018 Feb;14(2):97-98. doi: 10.1200/JOP.18.00010.
本文引用的文献
1
Challenges with Novel Clinical Trial Designs: Master Protocols.新型临床试验设计面临的挑战：主方案。
Clin Cancer Res. 2019 Apr 1;25(7):2049-2057. doi: 10.1158/1078-0432.CCR-18-3544. Epub 2019 Jan 29.
2
Is Precision Medicine an Oxymoron?精准医学是一种矛盾修辞法吗？
JAMA Oncol. 2019 Feb 1;5(2):142-143. doi: 10.1001/jamaoncol.2018.5099.
3
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.拉罗替尼在成人和儿童TRK融合阳性癌症中的疗效。
N Engl J Med. 2018 Feb 22;378(8):731-739. doi: 10.1056/NEJMoa1714448.
4
Future cancer research priorities in the USA: a Lancet Oncology Commission.美国未来癌症研究重点：《柳叶刀·肿瘤学》委员会报告
Lancet Oncol. 2017 Nov;18(11):e653-e706. doi: 10.1016/S1470-2045(17)30698-8. Epub 2017 Oct 31.
5
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.基因组异质性是胃食管腺癌精准医疗的障碍。
Cancer Discov. 2018 Jan;8(1):37-48. doi: 10.1158/2159-8290.CD-17-0395. Epub 2017 Oct 4.
6
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both.用于研究多种疗法、多种疾病或两者兼有的主方案。
N Engl J Med. 2017 Jul 6;377(1):62-70. doi: 10.1056/NEJMra1510062.
7
Limits to Personalized Cancer Medicine.个性化癌症医学的局限性。
N Engl J Med. 2016 Sep 29;375(13):1289-94. doi: 10.1056/NEJMsb1607705.
8
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.基于肿瘤分子谱的分子靶向治疗与晚期癌症的常规治疗（SHIVA）：一项多中心、开放标签、概念验证、随机、对照的 2 期临床试验。
Lancet Oncol. 2015 Oct;16(13):1324-34. doi: 10.1016/S1470-2045(15)00188-6. Epub 2015 Sep 3.
9
Application of molecular profiling in clinical trials for advanced metastatic cancers.分子谱分析在晚期转移性癌症临床试验中的应用。
J Natl Cancer Inst. 2015 Feb 6;107(4). doi: 10.1093/jnci/djv003. Print 2015 Apr.
10
Translational research in oncology--10 years of progress and future prospects.肿瘤学转化研究——十年的进展与未来展望。
Nat Rev Clin Oncol. 2014 Nov;11(11):649-62. doi: 10.1038/nrclinonc.2014.158. Epub 2014 Oct 7.
Zotero 插件